1. Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES Insights from the DESERT cooperation
- Author
-
DE LUCA, Giuseppe, Dirksen, Mt, Spaulding, C, Kelbæk, H, Schalij, M, Thuesen, L, van der Hoeven, B, Vink, Ma, Kaiser, C, Musto, C, Chechi, T, Spaziani, G, Diaz de la Llera LS, Pasceri, V, Di Lorenzo, E, Violini, R, Suryapranata, H, Stone, Gw, and Desert, Cooperation
- Subjects
Male ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,Myocardial Infarction ,Drug-Eluting Stents ,Middle Aged ,DES ,Treatment Outcome ,ST elevation myocardial infarction ,Metals ,Hypertension ,Humans ,Female ,Angioplasty, Balloon, Coronary ,BMS ,BMS, DES, Hypertension, Primary angioplasty, ST elevation myocardial infarction ,Aged ,Follow-Up Studies ,Randomized Controlled Trials as Topic ,Primary angioplasty - Abstract
Item does not contain fulltext BACKGROUND: Hypertension is a well known risk factor for atherosclerosis. However, data on the prognostic impact of hypertension in patients with ST elevation myocardial infarction (STEMI) are inconsistent and mainly related to studies performed in the thrombolytic era, with very few data in patients undergoing primary angioplasty. Therefore, the aim of the current study was to evaluate the impact hypertension on clinical outcome in STEMI patients undergoing primary PCI with BMS or DES. METHODS: Our population is represented by 6298 STEMI patients undergoing primary angioplasty included in the DESERT database from 11 randomized trials comparing DES vs BMS for STEMI. RESULTS: Hypertension was observed in 2764 patients (43.9%), and associated with ageing (p
- Published
- 2014